Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer

Hellmann, MD; Paz-Ares, L; Caro, RB; Zurawski, B; Kim, SW; Costa, EC; Park, K; Alexandru, A; Lupinacci, L; Jimenez, ED; Sakai, H; Albert, I; Vergnenegre, A; Peters, S; Syrigos, K; Barlesi, F; Reck, M; Borghaei, H; Brahmer, JR; O'Byrne, KJ; Geese, WJ;

Hellmann, MD (reprint author), Mem Sloan Kettering Canc Ctr, Dept Med, Div Solid Tumor Oncol, Thorac Oncol Serv, 885 2nd Ave, New York, NY 10017 USA.

NEW ENGLAND JOURNAL OF MEDICINE, 2019; 381 (21): 2020

Abstract

BACKGROUND In an early-phase study involving patients with advanced non-small-cell lung cancer (NSCLC), the response rate was better with nivolumab pl......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索